awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38443343-C8420092-9BD0-45A4-A6EE-FA8A2C3E6F03
Q38443343-C8420092-9BD0-45A4-A6EE-FA8A2C3E6F03
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38443343-C8420092-9BD0-45A4-A6EE-FA8A2C3E6F03
A double-blind, randomized, placebo-controlled study to assess the safety, antiviral activity and pharmacokinetics of GSK2336805 when given as monotherapy and in combination with peginterferon alfa-2a and ribavirin in hepatitis C virus genotype 1-in
P2860
Q38443343-C8420092-9BD0-45A4-A6EE-FA8A2C3E6F03
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38443343-C8420092-9BD0-45A4-A6EE-FA8A2C3E6F03
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bcf5867e0e9265565f308c294f534edeeaf5ed70
P2860
Safety, tolerability, pharmacokinetics, and antiviral activity of GSK2336805, an inhibitor of hepatitis C virus (HCV) NS5A, in healthy subjects and subjects chronically infected with HCV genotype 1